Woodline Partners’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.27M | Sell |
150,478
-56,000
| -27% | -$1.22M | 0.02% | 636 |
|
|
2025
Q1 | $5.01M | Sell |
206,478
-46,491
| -18% | -$1.13M | 0.03% | 510 |
|
|
2024
Q4 | $5.28M | Sell |
252,969
-53,489
| -17% | -$1.12M | 0.04% | 475 |
|
|
2024
Q3 | $6.09M | Sell |
306,458
-197,277
| -39% | -$3.92M | 0.05% | 364 |
|
|
2024
Q2 | $7.8M | Sell |
503,735
-23
| -0% | -$356 | 0.07% | 280 |
|
|
2024
Q1 | $8.03M | Buy |
+503,758
| New | +$8.03M | 0.07% | 298 |
|
|
2023
Q3 | – | Sell |
-253,325
| Closed | -$3.4M | – | 617 |
|
|
2023
Q2 | $3.4M | Buy |
+253,325
| New | +$3.4M | 0.04% | 353 |
|